ITGAM and neoplasm: Additionally, VAP-1 has been proposed to promote tumor growth by facilitating the recruitment of Gr-1+CD11b+ myeloid cells into tumors, and increase cancer cell extravasation and angiogenesis in melanoma and lymphoma (39, 40).